CorMedix (CRMD) Enterprise Value (2010 - 2025)

CorMedix (CRMD) has 16 years of Enterprise Value data on file, last reported at -$155.2 million in Q4 2025.

• For the quarter ending Q4 2025, Enterprise Value fell 200.27% year-over-year to -$155.2 million; the trailing twelve-month figure through Dec 2025 stood at -$155.2 million (down 200.27% YoY), and the FY2025 full-year result was -$155.2 million, down 200.27% from the prior year.
• Enterprise Value slipped to -$155.2 million in Q4 2025, from -$56.6 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$22.7 million in Q1 2022 to a low of -$190.7 million in Q2 2025.
• A 5-year average of -$65.9 million and a median of -$57.6 million in 2024 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value plunged 42266.88% in 2021 and soared 72.03% in 2022, its largest moves.
• Tracing CRMD's Enterprise Value over 5 years: stood at -$65.5 million in 2021, then surged by 33.9% to -$43.3 million in 2022, then tumbled by 75.7% to -$76.0 million in 2023, then jumped by 32.02% to -$51.7 million in 2024, then plunged by 200.27% to -$155.2 million in 2025.
• Business Quant data shows CRMD's Enterprise Value at -$155.2 million in Q4 2025, -$56.6 million in Q3 2025, and -$190.7 million in Q2 2025.